Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Corporate profit growth rose in Q3 2023 and is expected to continue in Q1.
Spotify To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Beyond The Numbers: 7 Analysts Discuss Quest Diagnostics Stock
Analysts’ ratings for Quest Diagnostics (NYSE:DGX) over the last quarter vary from bullish to bearish, as provided by…
Earnings Scheduled For February 1, 2024
Companies Reporting Before The Bell
• ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter.
• Shell (NYSE:SHEL) is likely to report quarterly earnings at $1.81 per share on revenue of $75.66 billion.
Investor Sentiment Falls Sharply Following Fed’s Rate Decision; Dow Dips Over 300 Points
The CNN Money Fear and Greed index showed a sharp decline in the overall market sentiment, while the index remained in the "Greed" zone on Wednesday.
Quest Diagnostics Likely To Report Higher Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts
Quest Diagnostics Incorporated (NYSE: DGX) is expected to release earnings results for its fourth quarter, before the opening bell on Feb. 1, 2024.
Earnings Outlook For Quest Diagnostics
Quest Diagnostics (NYSE:DGX) is set to give its latest quarterly earnings report on Thursday, 2024-02-01. Here’s what investors…
Fitbit And Quest Diagnostics Collaborate To Advance Research On The Use Of Wearable Devices To Improve Metabolic Health
Study to evaluate how behavioral and sensor data from wearables and blood tests can be leveraged to help individuals better assess and manage their metabolic healthSECAUCUS, N.J., Jan. 17, 2024 /PRNewswire/
Evolving Landscape For Alzheimer’s Blood Tests Gains Momentum Amid Inaccuracy Concerns
A less invasive alternative to PET scans, these tests offer quick identification for emerging treatments. Learn more about the latest advancements in Alzheimer's detection.
Quest Diagnostics And Ultima Collaborate To Scale Ultima’s Technology In Fast-Growing Minimal Residual Disease And Whole Genome Sequencing
Goal to combine Ultima's highly sensitive, low-cost technology with Quest's oncology expertise and national scale in order to improve patient access, affordability and outcomesUltima Genomics, a developer of a